Alphatec Holdings Announces Appointment of Michael O'Neill, FCMA, as Chief Financial Officer
BY EDITOR, OCTOBER 11, 2010
Alphatec Holdings, Inc. (NASDAQ: ATEC), the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures, and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, today announced the appointment of Michael O'Neill, FCMA, as the Company's Chief Financial Officer, Vice President and Treasurer, effective October 11, 2010. Peter C. Wulff will transition to the newly created position of Senior Vice President, Strategic Initiatives, effective immediately.
Mr. O'Neill joins the Company from Mentor Corporation, a surgical aesthetics manufacturer, where he was Vice President and Chief Financial Officer from November 2007 to March 2009. Mentor Corporation was acquired by Johnson & Johnson in January 2009. Prior to joining Mentor Corporation, Mr. O'Neill had spent the previous twenty years with Johnson & Johnson, with his most-recent position being Vice President and Chief Financial Officer, Johnson & Johnson Worldwide Information Technology. From 2001 through 2007 Mr. O'Neill served as the Vice President, Finance and Chief Financial Officer for LifeScan, a division of Johnson & Johnson, a leading supplier of blood glucose monitoring systems. Mr. O'Neill began working for Johnson & Johnson in 1987 and moved through a series of progressively more responsible positions including International Controller, Operations Controller, Finance Director, and Group Finance Director. Mr. O'Neill received a B.A. in Economics and Statistics from the University of Exeter, Devon, United Kingdom and is a Fellow of the Chartered Institute of Management Accountants of Great Britain.
Dirk Kuyper, the Company's President and Chief Executive Officer, commented, "We are extremely excited to welcome an experienced professional such as Mike to Alphatec Spine's management team. Mike's depth of knowledge in the medical device industry and experience with multi-national operations will allow him to quickly add value as the Company's CFO."
In his new position, Mr. Wulff will continue to report to the Company's President and CEO, Dirk Kuyper. Mr. Wulff's responsibilities will include a number of key initiatives and projects as well as the continued integration of Scient'x and Alphatec Spine.
Mr. Kuyper stated, "In the changing environment facing our industry, we believe that it is necessary to have a member of senior management that is focused on certain aspects of our strategic plan, including the Scient'x integration. We believe that Peter's experience and skill set are a good fit for this new role. I would like to thank Peter for the leadership role he provided during his tenure as CFO."
